Is budget impact analysis a poor cousin to health technology assessment and economic evaluation? Should we be doing better? What do different stakeholders need from these analyses to ensure health technologies are appropriately funded? Join us in a discussion of these and other budget impact issues with stakeholders across the PBAC process.
Introduction to Infectious Disease Modelling and Presentation of the Australian Covid-19 model Confirmed speakers Associate Professor Anthony Newall, UNSW Associate Professor James Woods, UNSW Dr Rob Moss, University of Melbourne
Join Professor Nancy Devlin from the University of Melbourne and the immediate past president of ISPOR, and Dr Ingrid Cox from the University of Tasmania and the current president of the student chapter in the first opening webinar for the newly formed ISPOR Victoria and Tasmania Student Chapter. Learn more about ISPOR and the role […]
The Virtual ISPOR Asia Pacific 2020 -- Next Generation Healthcare in Asia Pacific: Where Technology Meets Patients to Improve Care, is scheduled virtually over the dates of 14-16 September 2020. Your registration fee for Virtual ISPOR Asia Pacific 2020 will include the 3 days of programming 14-16 September, as well as a subscription to access all content from the virtual […]
In recent months, COVID-19 has reminded us how interventions intended to influence the course of a disease, have an impact that goes beyond the individual’s health. In fact, Governments have grappled with the trade-offs to be made when making decisions on interventions that adversely impact the economy but have the potential to save lives and/or improve health. In […]
A special webinar hosted by the ISPOR-AC Victoria and Tasmania Student Chapter Public health practitioners with expertise in health economics and outcomes research work in a broad range of areas and disciplines. In this webinar hosted by the ISPOR Victoria and Tasmania Student Chapter, students will be able to hear from four guest speakers as […]
Perspectives from academia, industry, and government advisory committee. Confirmed speakers: Professor Henry Glick, University of Pennsylvania Professor Cathy Mihalopoulos, Deakin University A/Professor Kim Dalziel, University of Melbourne Greg O’Toole, AstraZeneca Register free before 30th November.
Join ISPOR-AC on 15th March at 12pm for the annual ISPOR-AC AGM. The Annual General Meeting will be held online and by phone. Proceedings and the nomination form are available in the Member's section: https://isporac.org/members-section/agm/ Committee positions up for election include: President-elect Secretary Treasurer Student Representative (must be part of a Student Chapter to be […]
Please click here to register: https://utsmeet.zoom.us/meeting/register/tZEqcOusrDkrHdM0WrIbTocGWB36H55af02r COVID-19 continues to be a major disruption internationally. It has fundamentally changed policy settings and the thinking of both the population and policy makers about how we allocate government resources, and the appropriateness of imposing restrictions that may reduce individual freedom and curtail the economy on the one hand […]
Thursday 27th May | 9:00AM-3:30PM AEST ISPOR Victoria and Tasmania Chapter in collaboration with ISPOR Sydney Student and ECR Chapter warmly invites you to the first ISPOR Student Chapter Symposium in Australia to be held virtually on Thursday May 27, 9:00AM-3:30PM (AEST). The entirely virtual symposium is intended as an annual event where students and […]
Tumour Agnostic Therapies ISPOR-AC Lunchtime Webinar series Tuesday, 1st June @ 10:00am-12:00pm (AEST) In the next decade, cancer care will be transformed as genomics enables increasingly personalised medicine. New tumour agnostic drugs will continue to enter the market in the future, increasing the demand on HTA assessment. Tumour agnostic drugs have specific challenges relating to […]